|
|
Eli Lilly & Co CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/27/2026 15:59
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization1,485,483 mln
Float32,627 mln
Earnings Date10/29/2026
Key Fundamentals
EPS1.07
P/E42.72
ROE99.90
ROIC30.81
ROA22.74
Interest Cover131
EBITDA, mln49,746
EV / EBITDA30.66
EV / EBIT32.56
Revenue, mln110,102
EV / Revenue13.86
Quote Details
Last
45.71
Change
0.05 (0.11%)
Open
45.50
Volume
42,076
Turnover
1,923,294
Average Volume
94,173
Financial Ratios
Pre-Tax Profit Margin42
Leverage Ratio4.20
Current Ratio1.36
Price / Book32.92
Price / Tangible Book163
Price / Cash Flow40.47
Price / Free Cash Flow58.47
Debt / Equity1.62
Price / Sales13.49
PEG Ratio1.42
Financial Strength
Altman Z-Score7.97
Piotroski F-Score
9
/ 9
Beneish M-Score-2.04
Price to Intrinsic Value8.59
Price to Lynch Fair Value1.39
Price to Graham Number15.80
Shiller PE Ratio125
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-0.31% |
38
/ 100
 |
| 1 Month |
8.21% |
91
/ 100
 |
| 2 Months |
11.35% |
84
/ 100
 |
| 6 Months |
46.45% |
97
/ 100
 |
|
| |
